The major players in the healthcare associated infections treatment market include HORIBA, Ltd., BD., bioMérieux, Danaher, F. Hoffmann-La Roche Ltd, Meridian Bioscience, QIAGEN, ASP, Fortive, Johnson & Johnson Services, 3M, STERIS plc., Getinge AB., Cantel Medical., Belimed, Trinity Biotech, DiaSorin, OpGen, Accelerate Diagnostics, Thermo Fisher Scientific, Bio-Rad, Luminex Corporation., Quidel Corporation.
The treatment plan for HAI includes the use of antibiotics, antiviral and antifungal drugs, ventilators, and other therapies. The global market for HAI treatment is growing rapidly, owing to the increasing prevalence of HAI. The other factors that are contributing to the market are reduced immunity of the people, overcrowded hospitals, rapidly spreading contagious diseases, contaminated hospital devices, growing bacterial resistance to the routinely used antibiotics. During COVID-19, the global HAI treatment market is expected to increase, owing to rapidly spreading pandemic and overcrowded hospitals.
By Product
- Consumables
- Analyzers/Instruments
By Pathogens
- Viral
- Bacterial
- Fungal
By Treatment
- Sterilization
- Chemical
- Radiation
By Type of Infections
- Urinary Tract Infections
- Surgical Site Infections
- Hospital-Acquired Pneumonia
- Bloodstream Infections
- Gastrointestinal Infections
- Respiratory Infections
- Other Healthcare-Associated Infections
By Diagnostics Test
- Traditional Diagnostics
- Molecular Diagnostics
By End Use
- Hospitals
- Clinics
- ASCs
- Others
Source: https://www.valuemarketresearch.com/report/healthcare-associated-infections-treatment-market
Naira Shekhawat has been into Content Writing just after completing her Graduation in English Literature. Her love for words has won her many accolades in her respective jobs ever since. Naira covers business sections for VMR News. She is a traveller by heart and loves writing on food blogs as a freelancer.